-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shijiazhuang No.4 Pharmaceutical Welcomes the Certification Audit of Its Intellectual Property Management System
Category:
Time：2020-05-26
From May 22 to 23, a team from Zhongzhi (Beijing) Certification Co., Ltd. conducted a two-day audit of the operation of the intellectual property management system at Shijiazhuang No.4 Pharmaceutical Co., Ltd.
From May 22 to 23, a team from Zhongzhi (Beijing) Certification Co., Ltd. conducted a two-day audit of the operation of the intellectual property management system at Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
During the inspection, the review experts conducted an in-depth and meticulous examination of the company’s intellectual property management system—including product R&D, production and operations, and related management—through discussions with representatives from management.
At the final meeting, the expert panel stated that the company’s intellectual property management system continues to meet and effectively fulfill the relevant requirements, and agreed to recommend maintaining its certification status.
In recent years, Shijiazhuang No.4 Pharmaceutical has continuously improved its intellectual property management system in the course of innovation and creative development, conducted strategic research and implementation on intellectual property, intensified intellectual property training, and established a scientific intellectual property management process. In May 2018, the company obtained certification for its intellectual property management system; in 2019, it was recognized as a “National Intellectual Property Advantage Enterprise.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license